Analytical and Clinical Performance of the NeuMoDx™ Platform for Cytomegalovirus and Epstein-Barr Virus Viral Load Testing

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2024 May 25

PMID 38793553

Authors

Lindsay Coupland

Katy Woodward

Samir Dervisevic

Rachel Hale

Stephen Brolly

Affiliations

Soon will be listed here.

Abstract

DNA assays for viral load (VL) monitoring are key tools in the management of immunocompromised patients with cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection. In this study, the analytical and clinical performances of the NeuMoDx™ CMV and EBV Quant Assays were compared with artus CMV and EBV QS-RGQ Kits in a primary hospital testing laboratory. Patient plasma samples previously tested using artus kits were randomly selected for testing by NeuMoDx assays. The NeuMoDx CMV Quant Assay and artus CMV QS-RGQ Kit limits of detection (LoDs) are 20.0 IU/mL and 69.7 IU/mL, respectively; 33/75 (44.0%) samples had CMV DNA levels above the LoD of both assays. The Pearson correlation coefficient was 0.9503; 20 samples (60.6%) had lower NeuMoDx CMV quantification values versus the artus kit. The LoD of the NeuMoDx EBV Quant Assay and artus EBV QS-RGQ Kit are 200 IU/mL and 22.29 IU/mL, respectively; 16/75 (21.3%) samples had EBV DNA levels above the LoD of both assays. The Pearson correlation coefficient was 0.8990. EBV quantification values with the NeuMoDx assay were higher versus the artus kit in 15 samples (93.8%). In conclusion, NeuMoDx CMV and EBV Quant Assays are sensitive and accurate tools for CMV and EBV DNA VL quantification.

References

Styczynski J, van der Velden W, Fox C, Engelhard D, de la Camara R, Cordonnier C . Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016; 101(7):803-11. PMC: 5004459. DOI: 10.3324/haematol.2016.144428. View

Hayden R, Tang L, Su Y, Cook L, Gu Z, Jerome K . Impact of Fragmentation on Commutability of Epstein-Barr Virus and Cytomegalovirus Quantitative Standards. J Clin Microbiol. 2019; 58(1). PMC: 6935903. DOI: 10.1128/JCM.00888-19. View

Nogalski M, Collins-McMillen D, Yurochko A . Overview of human cytomegalovirus pathogenesis. Methods Mol Biol. 2014; 1119:15-28. DOI: 10.1007/978-1-62703-788-4_2. View

Mayer F, Ratzinger F, Schmidt R, Greiner G, Landt O, Am Ende A . Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speed. Virulence. 2020; 11(1):964-967. PMC: 7549918. DOI: 10.1080/21505594.2020.1798041. View

Jones S, Webb E, Barry C, Choi W, Abravaya K, Schneider G . Commutability of Cytomegalovirus WHO International Standard in Different Matrices. J Clin Microbiol. 2016; 54(6):1512-1519. PMC: 4879292. DOI: 10.1128/JCM.03292-15. View

Herdina A, Ratzinger F, Breuer M, Schellnegger J, Chen R, Watkins-Riedel T . Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula. Microbiol Spectr. 2022; 10(6):e0215722. PMC: 9769568. DOI: 10.1128/spectrum.02157-22. View

Abeynayake J, Johnson R, Libiran P, Sahoo M, Cao H, Bowen R . Commutability of the Epstein-Barr virus WHO international standard across two quantitative PCR methods. J Clin Microbiol. 2014; 52(10):3802-4. PMC: 4187779. DOI: 10.1128/JCM.01676-14. View

Marsh R . Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis. Front Immunol. 2018; 8:1902. PMC: 5766650. DOI: 10.3389/fimmu.2017.01902. View

Griffiths P, Reeves M . Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021; 19(12):759-773. PMC: 8223196. DOI: 10.1038/s41579-021-00582-z. View

10.

Mourik K, Boers S, van Rijn A, Thijssen J, Doorn R, Svraka S . Evaluation of the sample-to-result, random access NeuMoDx platform for viral load testing of Cytomegalovirus and Epstein Barr virus in clinical specimens. J Clin Virol. 2022; 149:105122. DOI: 10.1016/j.jcv.2022.105122. View

11.

Hayden R, Gu Z, Sam S, Sun Y, Tang L, Pounds S . Comparative evaluation of three commercial quantitative cytomegalovirus standards by use of digital and real-time PCR. J Clin Microbiol. 2015; 53(5):1500-5. PMC: 4400765. DOI: 10.1128/JCM.03375-14. View

12.

Cohen J . Epstein-Barr virus infection. N Engl J Med. 2000; 343(7):481-92. DOI: 10.1056/NEJM200008173430707. View

13.

Razonable R, Humar A . Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13512. DOI: 10.1111/ctr.13512. View

14.

Fugl A, Andersen C . Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract. 2019; 20(1):62. PMC: 6518816. DOI: 10.1186/s12875-019-0954-3. View

15.

Roh J, Kim S, Kwak E, Park J, Park Y . Performance evaluation of the Roche cobas 6800 system for quantifying cytomegalovirus DNA in plasma and urine samples. J Clin Virol. 2021; 138:104816. DOI: 10.1016/j.jcv.2021.104816. View

16.

Burd E . Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010; 23(3):550-76. PMC: 2901657. DOI: 10.1128/CMR.00074-09. View

17.

Luciani L, Mongin D, Ninove L, Nougairede A, Bardy K, Gazin C . Cytomegalovirus Viral Load in Transplanted Patients Using the NeuMoDx™ (Qiagen) Automated System: A 1-Month Experience Feedback. Viruses. 2021; 13(8). PMC: 8402845. DOI: 10.3390/v13081619. View

18.

Baron A, Gicquel A, Plantier J, Gueudin M . Evaluation of four commercial extraction-quantification systems to monitor EBV or CMV viral load in whole blood. J Clin Virol. 2019; 113:39-44. DOI: 10.1016/j.jcv.2019.03.001. View

19.

Ljungman P, Boeckh M, Hirsch H, Josephson F, Lundgren J, Nichols G . Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 2016; 64(1):87-91. DOI: 10.1093/cid/ciw668. View

20.

Lay M, Lucas R, Ratnamohan M, Taylor J, Ponsonby A, Dwyer D . Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J. 2010; 7:252. PMC: 2958162. DOI: 10.1186/1743-422X-7-252. View